Scientists test gentler start for promising leukemia drug
NCT ID NCT06697184
Summary
This study is testing new, potentially safer ways to start treatment with an experimental drug called sonrotoclax for adults with chronic lymphocytic leukemia (CLL). The goal is to find the best schedule for slowly increasing the drug dose at the beginning of treatment to reduce side effects, especially a serious one called tumor lysis syndrome. About 56 participants worldwide will help researchers determine which starting schedule is safest.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CHRONIC LYMPHOCYTIC LEUKEMIA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Blacktown Cancer and Haematology Centre
Blacktown, New South Wales, NSW 2148, Australia
-
Cabrini Hospital Malvern
Malvern East, Victoria, VIC 3144, Australia
-
Chu Dijon
Dijon, 21000, France
-
Chu Montpellier Hopital Saint Eloi
Montpellier, 34090, France
-
Dana Farber Cancer Institute
Boston, Massachusetts, 02215-5418, United States
-
Fort Wayne Medical Oncology and Hematology
Fort Wayne, Indiana, 46804, United States
-
Fred Hutchinson Cancer Research Center
Seattle, Washington, 98109-4433, United States
-
Genesiscare St Andrews
Adelaide, South Australia, SA 5000, Australia
-
Iuct Oncopole
Toulouse, 31100, France
-
Linear Clinical Research
Nedlands, Western Australia, WA 6009, Australia
-
Moffitt Cancer Center
Tampa, Florida, 33612-9496, United States
-
Queen Elizabeth Hospital
Birmingham, B15 2TH, United Kingdom
-
Rockingham Hospital
Cooloongup, Western Australia, WA 6168, Australia
-
St Jamess University Hospital
Leeds, LS9 7TF, United Kingdom
-
The Alfred Hospital
Melbourne, Victoria, VIC 3004, Australia
-
The University of Kansas Cancer Center
Westwood, Kansas, 66205-2003, United States
-
Washington University School of Medicine
St Louis, Missouri, 63110-1010, United States
Conditions
Explore the condition pages connected to this study.